A national shortage will result in BCCDC stocking out of RECOMBIVAX HB® Dialysis Formulation in late May/early June 2019. This shortage is expected to be resolved in January 2020. Hepatitis B ENGERIX® Adult vaccine will be available to be ordered as a substitute.
Currently, RECOMBIVAX HB® Dialysis Formulation is recommended for the immunization of clients with chronic kidney disease and HSCT recipients 20 years of age and older. Hepatitis B ENGERIX® Adult vaccine may be substituted for RECOMBIVAX HB® Dialysis Formulation, using the dose and schedule in the table below, as indicated in Part 4 – Biological Products, Hepatitis B Vaccine Program for Chronic Kidney Disease Clients and Hepatitis B Vaccine Higher Dose Schedule. Please do not delay the administration of Hepatitis B vaccine to these clients during this shortage.
Please note that if a client receives ENGERIX®-B vaccine as dose 1, the client will require a 4-dose series regardless of which vaccine is used to complete the series. If a client has received RECOMBIVAX HB® vaccine as dose 1, the client will only require a 3-dose series regardless of which vaccine is used to complete the series.
Please share this information with your nursing and biologicials management staff.
Christine Halpert RN BSN MA
Senior Practice Leader
Communicable Diseases and Immunization Service
BC Centre for Disease Control
Provincial Health Services Authority
655 West 12th Avenue
Vancouver, BC V5Z 4R4